Resources Contact Us Home
Assay for methylation in the GST-Pi gene

Image Number 10 for United States Patent #8088577.

A diagnostic or prognostic assay is disclosed for a disease of condition characterized by abnormal methylation of cytosine at side or sites within the glutathione-S-transferase (GST) Pi gene and/or its regulatory flanking sequences (e.g., prostate cancer and liver cancer). The assay comprises: (i) isolating DNA from said subject, and (ii) determining (e.g., by selective PCR amplification) the presence of abnormal methylation of cytosine at a site or sites within the GST-Pi gene and/or its regulatory flanking sequences.

  Recently Added Patents
Hypallergenic mosaic antigens and methods of making same
Systems and methods for computer-aided fold detection
Servo write assembly
Distributed multicast packet replication with centralized quality of service
Multiple angle bend for high-voltage lines
Base station apparatus and method for use in mobile communication system
  Randomly Featured Patents
Combination therapy of angiotensin converting enzyme inhibitor and aldosterone antagonist for reducing morbidity and mortality from cardiovascular disease
Apparatus and methods to remove impurities at a sensor in a downhole tool
Vehicle rear view mirror with indicator lamp
Fingerprint input apparatus
Compact interactive tabletop with projection-vision
High performance interdigitated coupler with additional jumper wire
Garment hanger carrier
Apparatus and method for measuring the concentration of gases
System and method for self-decaying digital media files and for validated playback of same
Multimodal conversation park and retrieval